CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
June 25th 2025
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
Updated Analysis of Prostate Cancer Trials Continue to Demonstrate Benefit with Xtandi
March 24th 2015Two studies investigating Xtandi in men with early-stage metastatic castration-resistant prostate cancer (mCRPC) further confirmed the overall survival (OS) and progression-free survival (PFS) benefit of the agent over placebo, according to two recent studies.
Evolving Role of Lymph Node Biopsies After Neoadjuvant Therapy for Breast Cancer
March 24th 2015Surgical oncologist Kelly K. Hunt, of MD Anderson Cancer Center, discusses how breast cancer interventions have progressed in the adjuvant and neoadjuvant setting and the role of sentinel lymph node dissection in the neoadjuvant setting.
The Evolving Challenges of Targeting PI3K in Breast Cancer
March 13th 2015Josh D. Lauring, of Johns Hopkins Medicine, is interested in identifying the genetic changes that drive breast cancer growth in order to determine novel therapeutic targets for drug development and ultimately improve outcomes for patients with breast cancer.
Higher Risk of Thyroid Cancer Among Those With Breast Cancer History
March 11th 2015According to a recent analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than the general population, particularly if they receive adjuvant radiation therapy.
Medical Updates from the 32nd Annual Miami Breast Cancer Conference
February 28th 2015The evolution of the treatment for hormone receptor-positive breast cancer was a hot topic for this year's Miami Breast Cancer Conference. Debu Tripathy, CURE's editor-in-chief and breast oncologist, reports from the meeting.
Experts Examine and Discuss the ER-Positive Breast Cancer Treatment Landscape
February 27th 2015The management of patients with hormone receptor (HR)-positive breast cancer continues to evolve, with phase 3 studies shedding light on the length of adjuvant anti-estrogen therapy, a novel treatment gaining approval, and new trials exploring combination strategies.
Chemobrain—It's Real, It's Complex, and the Science Is Still Evolving
February 17th 2015Talk with almost any cancer survivor, and he or she is likely to bring up the topic of "chemobrain," that fuzzy, murky state that patients blame for impaired memory. A review of the research shows how we're focusing on the problem.
Genetic Counseling and Testing Offers Important Information for Breast Cancer Patients
February 10th 2015Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven Hospital in Connecticut, discusses why certain patients should receive genetic counseling and testing for breast cancer.